Diversity in Clinical Trials Initiative
A partnership of our community, the Office of Healthcare Equity, the Human Subjects Division, UW Medicine, UW School of Medicine, and ITHS
Welcome to the official website dedicated to UW’s Diversity in Clinical Trials Initiative (DCTI). This initiative is inclusive of Washington Legislature House Bill 1745 as well as the guidance from the FDA regarding the equitable selection of clinical trial participants and development of a diversity plan. The Diversity in Clinical Trials Initiative aims to enhance representation of historically underrepresented communities among participants in clinical studies, ensuring that medical treatments and interventions are effectively studied across diverse populations, leading to more equitable healthcare outcomes for all individuals and better medicine. The University of Washington is taking this opportunity to review and revise our clinical trial policies with deeper and more comprehensive diversity criteria to usher in a new era of inclusive medical research.
This website will serve as a comprehensive resource hub, providing information, updates, and resources related to the DCTI and its implementation efforts.
Implementation of these policies will be gradual and phased in throughout the next year and will apply to new studies only. Existing clinical trials will not be subject to the new requirements. The effective date for compliance will be one year from publication of the new policies. Please see the timeline below for more details.